Vidaza injection 100mg, manufactured by Nippon Shinyaku, contains Azacitidine. This lyophilized product, with YJ code 4291419D1026 and standard 100mg 1 bottle, is approved for the treatment of myelodysplastic syndromes and acute myeloid leukemia.
Vidaza injection 100mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).